Delisting Determination,The Nasdaq Stock Market, LLC,
April 9, 2010, Commonwealth Biotechnologies, Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Commonwealth Biotechnologies, Inc.
(the Company), effective at the opening of the trading
session on April 19, 2010. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5550(b)(1), 5110(a), and 5100.
The Company was notified of the Staffs determination on
July 24, 2009 and July 31, 2009. Upon review of the
information provided by the Company, the Panel issed a decision
dated October 20, 2009, granting the Company continued
listing pursuant to an exception through January 20,
2010, by which date the Company was required to regain
compliance with Listing Rules 5550(b)(1), 5110(a) and 5100.
However, the Company did not regain compliance
by that date. On January 21, 2010, the Panel notified the
Company that trading in the Companys securities would be
suspended on January 22, 2010. The Company did not request a
review of the Panels decision by the Nasdaq Listing and
Hearing Review Council. The Listing Council did not call the
matter for review. The Panels Determination to delist
the Company became final on March 8, 2010.